The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial
Mosquera Orgueira, Adrian, Perez Encinas, Manuel, Diaz Arias, Jose Angel, Rodriguez Veiga, Rebeca, Bergua Burgues, Juan Miguel, Algarra, Jesús Lorenzo, Botella, Carmen, Perez Simon, Jose Antonio, Bernal, Teresa, Tormo, Mar, Calbacho, Maria, Salamero, Olga, Serrano, Josefina, Noriega, Victor, Lopez Lopez, Juan Antonio, Vives, Susana, Colorado, Mercedes, Lopez Lorenzo, Jose Luis, Vidriales Vicente, Maria, Garcia Boyero, Raimundo, Olave Rubio, Maria Teresa, Herrera Puente, Pilar, Arce, Olga, Barrios Garcia, Manuel, Sayas Lloris, Maria Jose, Polo, Marta, Gomez Roncero, Maria Isabel, Barragan, Eva, Ayala, Rosa, Chillon, Carmen, Calasanz, Maria Jose, Boluda, Blanca, Peleteiro Raindo, Andres, Amigo, Raquel, Martinez Cuadron, David, Labrador, Jorge, Montesinos, Pau
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Exploring Potential Molecular Mechanisms of Drug Response in FLT3-ITD Negative AML Patients Treated with Quizartinib Vs Placebo Plus Standard Chemotherapy in the Quiwi Trial
Mosquera Orgueira, Adrian, Perez Encinas, Manuel, Diaz Arias, Jose Angel, Rodriguez Veiga, Rebeca, Bergua Burgues, Juan Miguel, Algarra, Lorenzo, Botella, Carmen, Perez Simon, Jose Antonio, Bernal, Teresa, Tormo, Mar, Calbacho, Maria, Salamero, Olga, Serrano, Josefina, Noriega, Victor, Lopez Lopez, Juan Antonio, Vives, Susana, Colorado, Mercedes, Lopez Lorenzo, Jose Luis, Vidriales Vicente, Maria, Garcia Boyero, Raimundo, Olave Rubio, Maria Teresa, Herrera Puente, Pilar, Arce, Olga, Barrios Garcia, Manuel, Sayas Lloris, Maria Jose, Polo, Marta, Gomez Roncero, Maria Isabel, Barragan, Eva, Ayala, Rosa, Chillon, Carmen, Calasanz, Maria Jose, Boluda, Blanca, Peleteiro Raindo, Andres, Amigo, Raquel, Labrador, Jorge, Martinez Cuadron, David, Montesinos, Pau
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
Castaño-Bonilla, Tamara, Barragán, Eva, Sargas, Claudia, Sanz, Alejandro, Algarra, Lorenzo, Herrera-Puente, Pilar, García-Boyero, Raimundo, Barrios, Manuel, Martinez-Cuadron, David, Rodriguez-Veiga, Rebeca, Boluda, Blanca, Gil, Cristina, Serrano-López, Josefina, Martínez-López, Joaquín, Sayas-Lloris, María José, Olave, María Teresa, Riaza-Grau, Rosalía, Castillo, Teresa Bernal-Del, Larrayoz, María José, Amigo, Raquel, Jiménez-Velasco, Antonio, Sánchez, Joaquín, Ayala, Rosa, Blas, Carlos, Lainez, Daniel, Serrano-López, Juana, Sanz, Miguel A., Alonso-Domínguez, Juan M., Montesinos, Pau
Published in Disease markers (23.08.2022)
Published in Disease markers (23.08.2022)
Get full text
Journal Article